Is Oxford Immunotec Global PLC (OXFD) a Good Stock to Buy?

Consequently, key money managers were breaking ground themselves. Endurant Capital Management, led by Vishal Saluja and Pham Quang, assembled the most valuable position in Oxford Immunotec Global PLC (NASDAQ:OXFD). Endurant Capital Management had $1.4 million invested in the company at the end of the quarter. Philip Hempleman’s Ardsley Partners also initiated a $0.5 million position during the quarter.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Oxford Immunotec Global PLC (NASDAQ:OXFD) but similarly valued. These stocks are Community Healthcare Trust Inc (NYSE:CHCT), InVitae Corp (NYSE:NVTA), First Connecticut Bancorp Inc (NASDAQ:FBNK), and Gafisa SA (ADR) (NYSE:GFA). This group of stocks’ market valuations are closest to OXFD’s market valuation.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $38 million. That figure was $59 million in OXFD’s case. Community Healthcare Trust Inc (NYSE:CHCT) is the most popular stock in this table. On the other hand Gafisa SA (ADR) (NYSE:GFA) is the least popular one with only 3 bullish hedge fund positions. Oxford Immunotec Global PLC (NASDAQ:OXFD) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard CHCT might be a better candidate to consider taking a long position in.

Disclosure: None